Works matching IS 08876924 AND DT 2007 AND VI 21 AND IP 12

Results: 37

Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2519, doi. 10.1038/sj.leu.2404912

By:

Neri, P.;
Tassone, P.;
Shammas, M.;
Yasui, H.;
Schipani, E.;
Batchu, R. B.;
Blotta, S.;
Prabhala, R.;
Catley, L.;
Hamasaki, M.;
Hideshima, T.;
Chauhan, D.;
Jacob, G. S.;
Picker, D.;
Venuta, S.;
Anderson, K. C.;
Munshi, N. C.

Publication type:

Article

Pleiotropic p27Kip1, BCR-ABL and leukemic stem cell: the trio in concert.

Published in:

2007

By:

Sengupta, A.;
Banerjee, S.

Publication type:

Letter

Potential interaction of chemotherapy and gefitinib in the induction of hematologic neoplasia.

Published in:

2007

By:

Ravindranathan, M.;
Klementich, F. J.;
Jones, D. V.

Publication type:

Letter

Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma.

Published in:

2007

By:

Tagawa, H.;
Karube, K.;
Guo, Y.;
Takeshita, M.;
Kikuchi, M.;
Morishima, Y.;
Nakamura, S.;
Ohshima, K.;
Seto, M.

Publication type:

Letter

Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation.

Published in:

2007

By:

Reddiconto, G.;
Chiusolo, P.;
Fiorini, A.;
Farina, G.;
Laurenti, L.;
Martini, M.;
Marchetti, S.;
Fadda, G.;
Leone, G.;
Sica, S.

Publication type:

Letter

Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas.

Published in:

2007

By:

Porrata, L. F.;
Ristow, K.;
Witzig, T. E.;
Tuinistra, N.;
Habermann, T. M.;
Inwards, D. J.;
Ansell, S. M.;
Micallef, I. N.;
Johnston, P. B.;
Markovic, S. N.

Publication type:

Letter

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.

Published in:

2007

By:

Oran, B.;
Giralt, S.;
Couriel, D.;
Hosing, C.;
Shpall, E. J.;
de Meis, E.;
Khouri, I. F.;
Qazilbash, M.;
Anderlini, P.;
Kebriaei, P.;
Popat, U.;
Carrasco-Yalan, A.;
Champlin, R. E.;
de Lima, M.

Publication type:

Letter

Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2V617F mutational status.

Published in:

2007

By:

Ohyashiki, K.;
Akahane, D.;
Gotoh, A.;
Ito, Y.;
Tauchi, T.;
Miyazawa, K.;
Kimura, Y.;
Ohyashiki, J. H.

Publication type:

Letter

The CALM–AF10 fusion is a rare event in acute megakaryoblastic leukemia.

Published in:

2007

By:

Greiner, O.;
Bornhauser, B. C.;
Delabesse, E.;
Ballerini, P.;
Landman-Parker, J.;
Bourquin, J. P.

Publication type:

Letter

T cells from patients with polycythemia vera elaborate growth factors which contribute to endogenous erythroid and megakaryocyte colony formation.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2433, doi. 10.1038/sj.leu.2404899

By:

Ishii, T.;
Zhao, Y.;
Shi, J.;
Sozer, S.;
Hoffman, R.;
Xu, M.

Publication type:

Article

Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1-69.

Published in:

2007

By:

Walewska, R.;
Majid, A.;
Davis, Z.;
Dusanjh, P.;
Kennedy, D. B. J.;
Oscier, D. G.;
Dyer, M. J. S.

Publication type:

research

Modulation of cell apoptosis by AIR.

Published in:

2007

By:

Turco, M. C.;
Lamberti, A.;
Bisogni, R.;
Romano, M. F.;
Petrella, A.;
Ammirante, M.;
Rosati, A.;
Avenia, M. d'.;
Arra, C.;
Spugnini, E.;
Venuta, S.;
d' Avenia, M

Publication type:

Letter

Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning.

Published in:

2007

By:

Hoogendoorn, M.;
Jedema, I.;
Barge, R. M. Y.;
van Luxemburg-Heijs, S. A. P.;
Beaumont, F.;
Marijt, E. W. A.;
Willemze, R.;
Falkenburg, J. H. F.

Publication type:

Letter

Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2399, doi. 10.1038/sj.leu.2404911

By:

Humeniuk, R.;
Menon, L. G.;
Mishra, P. J.;
Saydam, G.;
Longo-Sorbello, G. S. A.;
Elisseyeff, Y.;
Lewis, L. D.;
Aracil, M.;
Jimeno, J.;
Bertino, J. R.;
Banerjee, D.

Publication type:

Article

Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma.

Published in:

2007

By:

Saito, B.;
Shiozawa, E.;
Usui, T.;
Nakashima, H.;
Maeda, T.;
Hattori, N.;
Shimozuma, J.;
Adachi, D.;
Yamochi-Onizuka, T.;
Takimoto, M.;
Nakamaki, T.;
Ota, H.;
Tomoyasu, S.

Publication type:

Letter

No evidence for amplification of V617F JAK2 in myeloproliferative disorders.

Published in:

2007

By:

Jones, A. V.;
Bunyan, D. J.;
Cross, N. C. P.

Publication type:

Letter

Familial polycythemia vera with non-germ line JAK2V617F mutation sparing the abnormal and clonal granulopoiesis.

Published in:

2007

By:

Hussein, K.;
Bock, O.;
Ballmaier, M.;
Göhring, G.;
Steinemann, D.;
Lehmann, U.;
Kemper, J.;
Buhr, T.;
Kreipe, H.

Publication type:

Letter

Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2420, doi. 10.1038/sj.leu.2404917

By:

Buesche, G.;
Ganser, A.;
Schlegelberger, B.;
von Neuhoff, N.;
Gadzicki, D.;
Hecker, H.;
Bock, O.;
Frye, B.;
Kreipe, H.

Publication type:

Article

MicroRNA losses in the frequently deleted region of 7q in SMZL.

Published in:

2007

By:

Ruiz-Ballesteros, E.;
Mollejo, M.;
Mateo, M.;
Algara, P.;
Martínez, P.;
Piris, M. A.

Publication type:

Letter

Reply to ‘Male preponderance in chronic lymphocytic leukemia utilizing IGHV1-69’ When size of the sample matters.

Published in:

2007

By:

Ghia, P.;
Belessi, C.;
Daví, F.;
Rosenquist, R.;
Stamatopoulos, K.

Publication type:

Letter

Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH).

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2463, doi. 10.1038/sj.leu.2404919

By:

Wessendorf, S.;
Barth, T. F. E.;
Viardot, A.;
Mueller, A.;
Kestler, H. A.;
Kohlhammer, H.;
Lichter, P.;
Bentz, M.;
Döhner, H.;
Möller, P.;
Schwaenen, C.

Publication type:

Article

FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2512, doi. 10.1038/sj.leu.2404913

By:

Gjerdrum, L. M.;
Woetmann, A.;
Odum, N.;
Burton, C. M.;
Rossen, K.;
Skovgaard, G. L.;
Ryder, L. P.;
Ralfkiaer, E.

Publication type:

Article

Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2442, doi. 10.1038/sj.leu.2404935

By:

Haferlach, C.;
Dicker, F.;
Schnittger, S.;
Kern, W.;
Haferlach, T.

Publication type:

Article

Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice.

Published in:

2007

By:

Roy, J.-S.;
Van Themsche, C.;
Demers, M.;
Opdenakker, G.;
Arnold, B.;
St-Pierre, Y.

Publication type:

journal article

FLT3 regulates β-catenin tyrosine phosphorylation, nuclear localization, and transcriptional activity in acute myeloid leukemia cells.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2476, doi. 10.1038/sj.leu.2404923

By:

Kajiguchi, T.;
Chung, E. J.;
Lee, S.;
Stine, A.;
Kiyoi, H.;
Naoe, T.;
Levis, M. J.;
Neckers, L.;
Trepel, J. B.

Publication type:

Article

Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells.

Published in:

2007

By:

Svensson, E.;
Vidovic, K.;
Lassen, C.;
Richter, J.;
Olofsson, T.;
Fioretos, T.;
Gullberg, U.

Publication type:

journal article

Genetically identical twin transplantation for chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2452, doi. 10.1038/sj.leu.2404928

By:

Pavletic, S. Z.;
Zhou, G.;
Sobocinski, K.;
Marti, G.;
Doney, K.;
DiPersio, J.;
Feremans, W.;
Foroni, L.;
Goodman, S.;
Prentice, G.;
LeMaistre, C.;
Bandini, G.;
Ferrant, A.;
Jacobsen, N.;
Khouri, I.;
Gale, R. P.;
Wiestner, A.;
Giralt, S.;
Montserrat, E.;
Chan, W. C.

Publication type:

Article

Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2527, doi. 10.1038/sj.leu.2404939

By:

Chim, C. S.;
Pang, R.;
Fung, T. K.;
Choi, C. L.;
Liang, R.

Publication type:

Article

Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40–CD40L interactions with T helper cells.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2411, doi. 10.1038/sj.leu.2404940

By:

Meers, S.;
Kasran, A.;
Boon, L.;
Lemmens, J.;
Ravoet, C.;
Boogaerts, M.;
Verhoef, G.;
Verfaillie, C.;
Delforge, M.

Publication type:

Article

Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2495, doi. 10.1038/sj.leu.2404961

By:

Tonks, A.;
Pearn, L.;
Musson, M.;
Gilkes, A.;
Mills, K. I.;
Burnett, A. K.;
Darley, R. L.

Publication type:

Article

Giuseppe Bigi (1944–2002).

Published in:

2007

By:

Sacchi, N.

Publication type:

Obituary

Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2456, doi. 10.1038/sj.leu.2404968

By:

Röth, A.;
Dürig, J.;
Himmelreich, H.;
Bug, S.;
Siebert, R.;
Dührsen, U.;
Lansdorp, P. M.;
Baerlocher, G. M.

Publication type:

Article

Cooperative transformation by MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins generated by the variant t(1;19) in acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2470, doi. 10.1038/sj.leu.2404962

By:

Prima, V.;
Hunger, S. P.

Publication type:

Article

The severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locus.

Published in:

2007

By:

Burgstaller, S.;
Kreil, S.;
Waghorn, K.;
Metzgeroth, G.;
Preudhomme, C.;
Zoi, K.;
White, H.;
Cilloni, D.;
Zoi, C.;
Brito-Babapulle, F.;
Walz, C.;
Reiter, A.;
Cross, N. C. P.

Publication type:

journal article

Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia.

Published in:

Leukemia (08876924), 2007, v. 21, n. 12, p. 2406, doi. 10.1038/sj.leu.2404975

By:

Niemann, C. U.;
Kjeldsen, L.;
Ralfkiaer, E.;
Jensen, M. K.;
Borregaard, N.

Publication type:

Article

JAK2-V617F activating mutation in acute myeloid leukemia: prognostic impact and association with other molecular markers.

Published in:

2007

By:

Vicente, C.;
Vázquez, I.;
Marcotegui, N.;
Conchillo, A.;
Carranza, C.;
Rivell, G.;
Bandrés, E.;
Cristobal, I.;
Lahortiga, I.;
Calasanz, M. J.;
Odero, M. D.

Publication type:

Correction Notice

Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia.

Published in:

2007

By:

Tse, E;
Chan, J C W;
Pang, A;
Au, W-Y;
Leung, A Y H;
Lam, C C K;
Kwong, Y-L

Publication type:

Correction Notice

Works matching IS 08876924 AND DT 2007 AND VI 21 AND IP 12

Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma.

Pleiotropic p27<sup>Kip1</sup>, BCR-ABL and leukemic stem cell: the trio in concert.

Potential interaction of chemotherapy and gefitinib in the induction of hematologic neoplasia.

Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma.

Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation.

Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas.

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.

Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2<sup>V617F</sup> mutational status.

The CALM–AF10 fusion is a rare event in acute megakaryoblastic leukemia.

T cells from patients with polycythemia vera elaborate growth factors which contribute to endogenous erythroid and megakaryocyte colony formation.

Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1-69.

Modulation of cell apoptosis by AIR.

Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning.

Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity.

Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma.

No evidence for amplification of V617F JAK2 in myeloproliferative disorders.

Familial polycythemia vera with non-germ line JAK2<sup>V617F</sup> mutation sparing the abnormal and clonal granulopoiesis.

Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia.

MicroRNA losses in the frequently deleted region of 7q in SMZL.

Reply to ‘Male preponderance in chronic lymphocytic leukemia utilizing IGHV1-69’ When size of the sample matters.

Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH).

FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.

Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV<sub>H</sub> status and immunophenotyping.

Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice.

FLT3 regulates β-catenin tyrosine phosphorylation, nuclear localization, and transcriptional activity in acute myeloid leukemia cells.

Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells.

Genetically identical twin transplantation for chronic lymphocytic leukemia.

Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.

Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40–CD40L interactions with T helper cells.

Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia.

Giuseppe Bigi (1944–2002).

Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia.

Cooperative transformation by MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins generated by the variant t(1;19) in acute lymphoblastic leukemia.

The severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locus.

Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia.

JAK2-V617F activating mutation in acute myeloid leukemia: prognostic impact and association with other molecular markers.

Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia.